Literature DB >> 2238471

Defective interfering particles: effects in modulating virus growth and persistence.

C R Bangham1, T B Kirkwood.   

Abstract

Defective interfering virus particles (DIP) frequently play an important part in viral persistence in vitro, and may in some instances modify a virus infection in vivo, causing attenuation or persistence of the infection. To explain certain aspects of the growth of these mutants in vitro, other factors have been invoked such as interferon, mutations in the wild-type virus or the infected cells, or other substances released by infected cells that attenuate the infection. We present here a simple model of the growth of DIP in vitro which shows that (a) the observed population dynamics of DIP can readily be explained without invoking such extrinsic factors; (b) the initial multiplicity of infection of DIP is the principal determinant of the outcome of infection in both single- and repeated-passage cultures; and (c) in a long-term culture in vitro, the criterion used to decide the time of virus passage directly determines how long the standard virus, DIP, and cells survive. This model may be used with minor modifications to predict the behavior in vitro of other mutant viruses with a dominantly interfering phenotype.

Entities:  

Mesh:

Year:  1990        PMID: 2238471     DOI: 10.1016/0042-6822(90)90150-p

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Passage effect of virus infection in insect cells.

Authors:  P J Krell
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Nonlinear trade-offs allow the cooperation game to evolve from Prisoner's Dilemma to Snowdrift.

Authors:  Lin Chao; Santiago F Elena
Journal:  Proc Biol Sci       Date:  2017-05-17       Impact factor: 5.349

3.  In vivo transmission and dynamics of deleted genomes after experimental infection of woodchuck hepatitis B virus in adult animals.

Authors:  Valentina La Sorsa; Claudio Argentini; Roberto Bruni; Umberta Villano; Roberto Giuseppetti; Maria Rapicetta
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

4.  A mutation in tomato aspermy cucumovirus that abolishes cell-to-cell movement is maintained to high levels in the viral RNA population by complementation.

Authors:  I M Moreno; J M Malpica; E Rodríguez-Cerezo; F García-Arenal
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Cycles, chaos, and evolution in virus cultures: a model of defective interfering particles.

Authors:  T B Kirkwood; C R Bangham
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

6.  Virus promoters determine interference by defective RNAs: selective amplification of mini-RNA vectors and rescue from cDNA by a 3' copy-back ambisense rabies virus.

Authors:  S Finke; K K Conzelmann
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  Complex dynamics of defective interfering baculoviruses during serial passage in insect cells.

Authors:  Mark P Zwart; Gorben P Pijlman; Josep Sardanyés; Jorge Duarte; Cristina Januário; Santiago F Elena
Journal:  J Biol Phys       Date:  2013-04-19       Impact factor: 1.365

8.  Characterization of a glial cell line persistently infected with borna disease virus (BDV): influence of neurotrophic factors on BDV protein and RNA expression.

Authors:  K M Carbone; S A Rubin; A M Sierra-Honigmann; H M Lederman
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Multiple-hit inhibition of infection by defective interfering particles.

Authors:  Kristen A Stauffer Thompson; Grzegorz A Rempala; John Yin
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

10.  Transcriptional and translational analyses of the UL2 gene of equine herpesvirus 1: a homolog of UL55 of herpes simplex virus type 1 that is maintained in the genome of defective interfering particles.

Authors:  R N Harty; V R Holden; D J O'Callaghan
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.